OnKure Therapeutics, Inc.
Statements
Cash Flow
OnKure Therapeutics, Inc. (OKUR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -52 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -19 | -38 | -27 | -35 | -51 | -52 | |
| 0.0 | 0.1 | 0.4 | 0.6 | 0.7 | 0.8 | |
| – | – | 0.0 | 0.2 | 4.5 | 12 | |
| 0.5 | -2.8 | 2.1 | 0.0 | -4.0 | -4.8 | |
| 0.0 | 0.2 | 1.1 | 0.2 | 0.1 | 0.0 | |
| 7.4 | -23 | -1.1 | -0.2 | 16 | 0.0 | |
| – | – | – | 0.0 | 6.0 | 0.0 | |
| 47 | 132 | 26 | 53 | 116 | 0.2 | |
| 36 | 71 | -1.6 | 18 | 81 | -52 | |
| -19 | -38 | -28 | -35 | -51 | -52 |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.